marginally significantp = 0.055
In Stage II, the post-treatment differences remained marginally significant (HADS-A: p = 0.055; HADS-D: p = 0.050; EORTC QLQ-H&N35: p = 0.065).
In Stage II, the post-treatment differences remained marginally significant (HADS-A: p = 0.055; HADS-D: p = 0.050; EORTC QLQ-H&N35: p = 0.065).